Cargando…
The Erythropoietin/Erythropoietin Receptor Signaling Pathway Promotes Growth and Invasion Abilities in Human Renal Carcinoma Cells
Co-expression of erythropoietin (Epo) and erythropoietin receptor (EpoR) has been found in various non-hematopoietic cancers including hereditary and sporadic renal cell carcinomas (RCC), but the Epo/EpoR autocrine and paracrine mechanisms in tumor progression have not yet been identified. In this s...
Autores principales: | Wu, Pengjie, Zhang, Ning, Wang, Xi, Zhang, Chi, Li, Teng, Ning, Xianghui, Gong, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445554/ https://www.ncbi.nlm.nih.gov/pubmed/23028796 http://dx.doi.org/10.1371/journal.pone.0045122 |
Ejemplares similares
-
Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
por: Khankin, Eliyahu V., et al.
Publicado: (2010) -
Erythropoietin and renal protection
por: Baradaran, Azar, et al.
Publicado: (2013) -
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
por: Gabutti, Luca, et al.
Publicado: (2011) -
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007) -
New insights into erythropoietin and erythropoietin receptor in laryngeal cancer tissue
por: Vukelic, Jelena, et al.
Publicado: (2021)